MX2020001825A - Compuestos triciclicos como inhibidores de metiltransferasa de histona. - Google Patents
Compuestos triciclicos como inhibidores de metiltransferasa de histona.Info
- Publication number
- MX2020001825A MX2020001825A MX2020001825A MX2020001825A MX2020001825A MX 2020001825 A MX2020001825 A MX 2020001825A MX 2020001825 A MX2020001825 A MX 2020001825A MX 2020001825 A MX2020001825 A MX 2020001825A MX 2020001825 A MX2020001825 A MX 2020001825A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- tricyclic compounds
- transferase inhibitors
- histone methyl
- glp
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 102000011787 Histone Methyltransferases Human genes 0.000 title abstract 2
- 108010036115 Histone Methyltransferases Proteins 0.000 title abstract 2
- 239000003697 methyltransferase inhibitor Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000005980 beta thalassemia Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000034737 hemoglobinopathy Diseases 0.000 abstract 1
- 208000018337 inherited hemoglobinopathy Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000007056 sickle cell anemia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762545936P | 2017-08-15 | 2017-08-15 | |
| US201862712864P | 2018-07-31 | 2018-07-31 | |
| PCT/US2018/046541 WO2019036377A1 (en) | 2017-08-15 | 2018-08-13 | TRICYCLIC COMPOUNDS AS HISTONE INHIBITORS METHYLTRANSFERASES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020001825A true MX2020001825A (es) | 2020-03-20 |
Family
ID=63452724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020001825A MX2020001825A (es) | 2017-08-15 | 2018-08-13 | Compuestos triciclicos como inhibidores de metiltransferasa de histona. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11661410B2 (OSRAM) |
| EP (1) | EP3668863B1 (OSRAM) |
| JP (1) | JP7267993B2 (OSRAM) |
| CN (1) | CN111372927A (OSRAM) |
| BR (1) | BR112020003073A2 (OSRAM) |
| ES (1) | ES3016407T3 (OSRAM) |
| IL (1) | IL272507A (OSRAM) |
| MX (1) | MX2020001825A (OSRAM) |
| SA (1) | SA520411303B1 (OSRAM) |
| SG (1) | SG11202001090WA (OSRAM) |
| TW (1) | TW201920136A (OSRAM) |
| WO (1) | WO2019036377A1 (OSRAM) |
| ZA (1) | ZA202001503B (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018195450A1 (en) | 2017-04-21 | 2018-10-25 | Epizyme, Inc. | Combination therapies with ehmt2 inhibitors |
| WO2019036384A1 (en) | 2017-08-15 | 2019-02-21 | Global Blood Therapeutics, Inc. | TRICYCLIC COMPOUNDS AS HISTONE INHIBITORS METHYLTRANSFERASES |
| CN116802182A (zh) * | 2021-03-15 | 2023-09-22 | 诺华股份有限公司 | 吡唑并吡啶衍生物及其用途 |
| CN116940571A (zh) * | 2021-03-15 | 2023-10-24 | 诺华股份有限公司 | 苯并异噁唑衍生物及其用途 |
| CA3239101A1 (en) * | 2021-11-25 | 2023-06-01 | Gang Deng | Tricyclic derivative and preparation method therefor and application thereof |
| CN118373805B (zh) * | 2024-03-06 | 2026-03-06 | 中山大学 | 一种nsd2小分子抑制剂及其制备方法及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US20170000784A1 (en) | 2013-12-08 | 2017-01-05 | Van Andel Research Institute | Autophagy Inhibitors |
| US9284272B2 (en) * | 2014-03-28 | 2016-03-15 | Abbvie Inc. | Inhibitors of histone methyltransferase G9a |
| CA2987978C (en) | 2014-06-16 | 2022-08-16 | Fundacion Para La Investigacion Medica Aplicada | Novel compounds as dual inhibitors of histone methyltransferases and dna methyltransferases |
| AU2016372280A1 (en) | 2015-12-14 | 2018-07-12 | Fundación Para La Investigación Médica Aplicada | 2,4,6,7-tetrasubstituted quinoline compounds as inhibitors of DNA methyltransferases |
| WO2017142947A1 (en) * | 2016-02-17 | 2017-08-24 | Global Blood Therapeutics, Inc. | Histone methyltransferase inhibitors |
| WO2019036384A1 (en) | 2017-08-15 | 2019-02-21 | Global Blood Therapeutics, Inc. | TRICYCLIC COMPOUNDS AS HISTONE INHIBITORS METHYLTRANSFERASES |
-
2018
- 2018-08-13 ES ES18762967T patent/ES3016407T3/es active Active
- 2018-08-13 US US16/639,051 patent/US11661410B2/en active Active
- 2018-08-13 CN CN201880064130.8A patent/CN111372927A/zh active Pending
- 2018-08-13 WO PCT/US2018/046541 patent/WO2019036377A1/en not_active Ceased
- 2018-08-13 JP JP2020508394A patent/JP7267993B2/ja active Active
- 2018-08-13 MX MX2020001825A patent/MX2020001825A/es unknown
- 2018-08-13 BR BR112020003073-2A patent/BR112020003073A2/pt not_active Application Discontinuation
- 2018-08-13 SG SG11202001090WA patent/SG11202001090WA/en unknown
- 2018-08-13 EP EP18762967.0A patent/EP3668863B1/en active Active
- 2018-08-14 TW TW107128321A patent/TW201920136A/zh unknown
-
2020
- 2020-02-06 IL IL272507A patent/IL272507A/en unknown
- 2020-02-11 SA SA520411303A patent/SA520411303B1/ar unknown
- 2020-03-10 ZA ZA2020/01503A patent/ZA202001503B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US11661410B2 (en) | 2023-05-30 |
| US20230002351A1 (en) | 2023-01-05 |
| SG11202001090WA (en) | 2020-03-30 |
| ZA202001503B (en) | 2023-07-26 |
| EP3668863B1 (en) | 2025-03-19 |
| TW201920136A (zh) | 2019-06-01 |
| EP3668863A1 (en) | 2020-06-24 |
| ES3016407T3 (en) | 2025-05-09 |
| IL272507A (en) | 2020-03-31 |
| JP2020531423A (ja) | 2020-11-05 |
| BR112020003073A2 (pt) | 2020-08-25 |
| CN111372927A (zh) | 2020-07-03 |
| SA520411303B1 (ar) | 2023-12-27 |
| EP3668863C0 (en) | 2025-03-19 |
| JP7267993B2 (ja) | 2023-05-02 |
| WO2019036377A1 (en) | 2019-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202401324B (en) | Tyrosine kinase inhibitors | |
| SA520411303B1 (ar) | مركبات ثلاثية الحلقات بوصفها مثبطات ناقلة ميثيل للهيستون | |
| PH12020550901A1 (en) | Macrocyclic compounds for treating disease | |
| SG10201811384TA (en) | Mnk inhibitors and methods related thereto | |
| PH12018500423A1 (en) | Inhibitors of ezh2 | |
| MX389597B (es) | Inhibidores de cdk2/4/6 de piridopirimidinona. | |
| TN2019000192A1 (en) | Pyrazole derivatives as malt1 inhibitors | |
| SA519410320B1 (ar) | مركبات فينيل -2-هيدروكسي-أسيتيل أمينو -2-ميثيل-فينيل | |
| PH12017500367B1 (en) | Compounds that inhibit mcl-1 protein | |
| PH12015502028A1 (en) | Ido inhibitors | |
| MX366875B (es) | Inhibidores de indoleamina 2,3-dioxigenasa (ido). | |
| PH12018501084A1 (en) | Heterocyclic compounds as immunomodulators | |
| MX376639B (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer. | |
| JOP20210128A1 (ar) | مركبات عطرية غير متجانسة كمثبطات Vanin | |
| PH12021550269A1 (en) | Heteroaromatic compounds as vanin inhibitors | |
| NZ756915A (en) | Dual magl and faah inhibitors | |
| PH12022551623A1 (en) | Substituted pyrazolo-pyrimidines and uses thereof | |
| MX2021012096A (es) | Compuestos de indenilo, composiciones farmaceuticas y usos medicos del mismo. | |
| MX2019014759A (es) | Compuestos de azaindol como inhibidores de metiltransferasa de histona. | |
| MX2021006490A (es) | Compuestos heteroaromaticos como inhibidores de vanina. | |
| WO2019036417A3 (en) | Inhibition of ngly1 for the treatment of cancer |